223 related articles for article (PubMed ID: 11097348)
1. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.
Grahovac B; Bingulac-Popovic J; Vucelic B; Hrstic I; Ostojic R; Drazic V; Balija M; Grgicevic D
J Clin Virol; 2001 Jan; 20(1-2):85-9. PubMed ID: 11163588
[TBL] [Abstract][Full Text] [Related]
3. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
4. Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.
Al-Qahtani AA; Kessie G; Dela Cruz D; Al-Faleh FZ; Al-Ahdal MN
Ann Saudi Med; 2010; 30(2):109-14. PubMed ID: 20220259
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy.
González-Peralta RP; Liu WZ; Davis GL; Qian KP; Lau JY
J Viral Hepat; 1997 Mar; 4(2):99-106. PubMed ID: 9097265
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].
López-Labrador FX; Ampurdanès S; Giménez-Barcons M; Guilera M; Costa J; Jiménez de Anta MT; Sánchez-Tapias JM; Rodés J; Sáiz JC
Hepatology; 1999 Mar; 29(3):897-903. PubMed ID: 10051495
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
von Wagner M; Lee JH; Rüster B; Kronenberger B; Sarrazin C; Roth WK; Zeuzem S
J Viral Hepat; 2003 Nov; 10(6):413-22. PubMed ID: 14633173
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study.
Hino K; Yamaguchi Y; Fujiwara D; Katoh Y; Korenaga M; Okazaki M; Okuda M; Okita K
J Viral Hepat; 2000 Jan; 7(1):36-42. PubMed ID: 10718941
[TBL] [Abstract][Full Text] [Related]
10. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.
Gerotto M; Sullivan DG; Polyak SJ; Chemello L; Cavalletto L; Pontisso P; Alberti A; Gretch DR
J Virol; 1999 Sep; 73(9):7241-7. PubMed ID: 10438811
[TBL] [Abstract][Full Text] [Related]
11. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
12. [Viral quasispecies and their implications in antiviral therapy].
Fernández B; Basaras M; Blanco S; Sánchez S; Arrese E; de las Heras B; Cisterna R
Rev Esp Quimioter; 2002 Mar; 15(1):49-54. PubMed ID: 12582437
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.
Le Guen B; Squadrito G; Nalpas B; Berthelot P; Pol S; Brechot C
Hepatology; 1997 May; 25(5):1250-4. PubMed ID: 9141446
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.
Bukowska-Ośko I; Pawełczyk A; Perlejewski K; Kubisa N; Caraballo Cortés K; Rosińska M; Płoski R; Fic M; Kaźmierczak J; Popiel M; Ząbek P; Horban A; Radkowski M; Laskus T
PLoS One; 2015; 10(5):e0125604. PubMed ID: 25932941
[TBL] [Abstract][Full Text] [Related]
16. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
Boulestin A; Sandres-Saune K; Alric L; Pipy B; Dubois M; Vinel JP; Izopet J
Antivir Ther; 2005; 10(4):499-504. PubMed ID: 16038475
[TBL] [Abstract][Full Text] [Related]
17. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
Yuen MF; Lai CL
Intervirology; 2006; 49(1-2):96-8. PubMed ID: 16166796
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]